In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussis components of a trivalent vaccine

被引:7
|
作者
Carlin, G [1 ]
Viitanen, E [1 ]
机构
[1] Med Prod Agcy, SE-75103 Uppsala, Sweden
关键词
diphtheria toxoid; IL-6; pyrogenicity;
D O I
10.1016/j.vaccine.2005.02.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have earlier found that a trivalent vaccine, containing antigenic components from both Gram-positive and Gram-negative bacteria, induced secretion of the endogenous pyrogen interleukin 6 (IL-6) when added to fresh human blood in vitro. The results of the present study showed that the IL-6 secretion was induced by toxoids derived from the Gram-positive bacterium Corynebacterium diphtheriae. However, fresh whole blood from different donors reacted differently to the stimulation. The blood from some donors induced secretion of large concentrations of IL-6, while the blood from other donors induced essentially no IL-6 secretion as a response to stimulation with diphtheria toxoid or a mixture of diphtheria and tetanus toxoids. Repeated testing over several years using blood from the same donor confirmed a donor-dependency of the reaction. This donor-dependency was only found for the toxoid, since blood from all donors reacted with approximately similar IL-6 production to stimulation by endotoxin from the Gram-negative bacterium Escherichia coli, known to be mediated via the toll-like receptor (TLR) 4. Also, no donor-dependecy was found to highly purified lipoteichoic acid from the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus, known to be mediated via TLR-2 and TLR-6. The receptors involved in stimulation by diphtheria toxoid are not known, but may differ from those used by endotoxin and lipoteichoic acid. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3709 / 3715
页数:7
相关论文
共 50 条
  • [2] Diphtheria-tetanus-acellular pertussis (DTaP) vaccine
    Howe, BJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1803 - 1803
  • [3] Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients
    Campbell, Neha Sirohi
    Kalman, Denise Diprimio
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (04) : 409 - 411
  • [4] Diphtheria-tetanus-acellular pertussis (DTaP) vaccine - Reply
    Marwick, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1804 - 1804
  • [5] Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
    Decker, Michael D.
    Hosbach, Phillip
    Johnson, David R.
    Pool, Vitali
    Greenberg, David P.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (03): : 497 - U79
  • [6] EVALUATION OF THE PERTUSSIS COMPONENTS OF DIPHTHERIA-TETANUS-PERTUSSIS VACCINE
    MURPHY, MD
    RASNACK, J
    DICKSON, HD
    DIETCH, M
    BRUNELL, PA
    [J]. PEDIATRICS, 1983, 71 (02) : 200 - 205
  • [7] Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997
    Ekwueme, DU
    Strebel, PM
    Hadler, SC
    Meltzer, MI
    Allen, JW
    Livengood, JR
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (08): : 797 - 803
  • [8] Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults
    Van Damme, P
    Burgess, M
    [J]. VACCINE, 2004, 22 (3-4) : 305 - 308
  • [9] Overview of the clinical development of a diphtheria-tetanus-acellular pertussis vaccine
    Bogaerts, H
    Capiau, C
    Hauser, P
    Mareschal, JC
    Melot, V
    Simons, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 : S276 - S280
  • [10] Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine Reply
    Koepke, Ruth
    Eickhoff, Jens C.
    Ayele, Roman A.
    Petit, Ashley B.
    Schauer, Stephanie L.
    Hopfensperger, Daniel J.
    Conway, James H.
    Davis, Jeffrey P.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (03): : 498 - 499